Literature DB >> 27798921

Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma.

Cecilie Gjøvaag Attramadal1, Sheeba Kumar2, Jian Gao2, Morten Ebbe Boysen3, Trond Sundby Halstensen2,4, Magne Bryne1.   

Abstract

BACKGROUND: The cellular composition of the tumor microenvironment (TME) at the invading front of oral squamous cell carcinomas (OSCCs) may reflect biologically important cancer features and host responses, and thus be related to disease progression. The TME density of mast cells (MCs), macrophages, cancer-associated fibroblasts (CAFs) and endothelial cells were quantified at the invasive front and analyzed regarding their relation to disease recurrence in patients with small T1/2N0M0 OSCCs. mRNA for MC-specific proteins were analyzed in a second patient cohort with head and neck squamous cell carcinoma (HNSCC).
MATERIALS AND METHODS: Samples from 62 patients with T1/2N0M0 OSCC were immunohistochemically stained and scored for the cellular expression of mast/stem cell growth factor receptor (c-KIT) (MCs), CD68 (macrophages), α-smooth muscle actin (α-SMA) (CAFs) and CD31 (endothelial cells) and this was analyzed according to disease recurrence. Data from The Cancer Genome Atlas database were used to examine mRNA expression profiles and clinical data of patients with 399 HNSCC.
RESULTS: Increased MC density at the invasive front was significantly associated with reduced disease recurrence, as none of the patients with high MC density experienced relapse. Moreover, increased expression of mRNA for MC specific markers as c-KIT, and α-, β-, and δ-tryptases and the MC-stimulating factor, stem cell factor (SCF), was significantly associated with good prognosis in patients with HNSCC.
CONCLUSION: Decreased MC density at the invasive front may reflect tumor biology related to disease progression and prognosis. Counting MCs seems to be an easy and practical tool, that could be utilized for prognostic evaluation. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Head and neck squamous cell carcinoma; invasive front; mast cell; prognosis

Mesh:

Year:  2016        PMID: 27798921     DOI: 10.21873/anticanres.11131

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Mast cell marker gene signature in head and neck squamous cell carcinoma.

Authors:  Zhimou Cai; Bingjie Tang; Lin Chen; Wenbin Lei
Journal:  BMC Cancer       Date:  2022-05-24       Impact factor: 4.638

2.  Evaluation of Mast Cell Density using CD117 antibody and Microvessel Density Using CD34 Antibody in Different Grades of Oral Squamous Cell Carcinoma.

Authors:  Fakeha Meraj Ansari; Muhammad Asif; Maryam Nazir Kiani; Nighat Ara; Muhammad Ishaque; Rabia Khan
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

Review 3.  Role of macrophages in tumor progression and therapy (Review).

Authors:  Yiwei Xu; Xiaomin Wang; Lijuan Liu; Jia Wang; Jibiao Wu; Changgang Sun
Journal:  Int J Oncol       Date:  2022-04-01       Impact factor: 5.650

Review 4.  Tumour-associated tissue eosinophilia (TATE) in oral squamous cell carcinoma: a comprehensive review.

Authors:  Marco Mascitti; Lucrezia Togni; Corrado Rubini; Giuseppe Troiano; Lorenzo Lo Muzio; Andrea Santarelli
Journal:  Histol Histopathol       Date:  2020-09-28       Impact factor: 2.303

5.  High mast cell density indicates a longer overall survival in oral squamous cell carcinoma.

Authors:  Phillipp Brockmeyer; Alexander Kling; Xenia Schulz; Christina Perske; Henning Schliephake; Bernhard Hemmerlein
Journal:  Sci Rep       Date:  2017-11-07       Impact factor: 4.379

6.  Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.

Authors:  Kyriakos Chatzopoulos; Sotiris Sotiriou; Andrea R Collins; Panagiotis Kartsidis; Alessandra C Schmitt; Xianfeng Chen; Khashayarsha Khazaie; Michael L Hinni; Colleen A Ramsower; Matthew A Zarka; Samir H Patel; Joaquin J Garcia
Journal:  Head Neck Pathol       Date:  2020-10-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.